- 1. 1,3-Butadiene
- [A synthetic, colorless gas that is practically insoluble in water and soluble in ethanol, ether, acetone and benzene. It is used primarily as a monomer to manufacture many different types of polymers and copolymers and as a chemical intermediate in the production of industrial chemicals. When heated, 1,3-butadiene emits acrid fumes and is flammable. In the presence of air, it oxidizes to form explosive peroxides. The primary route of potential human exposure to this compound is inhalation. Acute exposure to 1,3-butadiene can cause irritation of the eyes, nasal passages and throat. At very high concentrations, inhalation of this gas can result in headache, fatigue, decreased blood pressure and pulse rate, central nervous system damage and unconsciousness. It is known to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0043902) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 15. butanol
- [butyl alcohol (C4H9OH) and its isomeric forms and derivatives. ( CSP )] (UMLS (CSP) C0001977) =Lipid ;
|
- 2. 1,5-(butylimino)-1,5-dideoxy-D-glucitol
- [A synthetic, N-alkylated imino analogue of D-glucose. Miglustat competitively and reversibly binds to and inhibits the activity of UDP-glucose ceramide glucosyltransferase, which catalyzes the initial step in the synthesis of glycosphingolipids (GSL). This leads to a decrease in the production of glycosphingolipid, which has important roles in various cellular processes. Miglustat can be used in substrate reduction therapy in diseases in which the enzyme glucocerebrosidase, that is responsible for the breakdown of GSL, is deficient. ( NCI )] (UMLS (NCI) C1321596) 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-,(2R-(2alpha,3beta,4alpha,5beta))-;
MIGLUSTAT;
MIGLUSTAT PREPARATION;
N-Butyl Deoxynojirimycin;
N-Butylmoranoline =Organic Chemical; Pharmacologic Substance =[HS900] HORMONES/SYNTHETICS/MODIFIERS, OTHER;
Unclassified Ingredients =MIGLUSTAT 100 MG | - 16. Butenafine Hydrochloride
- [The hydrochloride salt form of butenafine, a synthetic benzylamine derivative with fungicidal properties. Butenafine hydrochloride interferes with the biosynthesis of ergosterol, an important component of fungal cell membranes, by inhibiting the epoxidation of squalene. This alters fungal membrane permeability and causes growth inhibition. Butenafine hydrochloride is active against a number of dermatophytes, including Trichophyton rubrum, Trichophyton mentagrophytes, Microsporum canis, Sporothrix schenckii, and yeasts, including Candida albicans and C. parapsilosis. ( NCI )] (UMLS (NCI) C0771847) BUTENAFINE HYDROCHLORIDE PREPARATION;
N-((4-(1,1-Dimethylethyl)phenyl)methyl)-N-methyl-1-naphthalenemethanamine Hydrochloride;
N-4-tert-Butylbenzyl-N-methyl-1-naphthalenemethylamine Hydrochloride;
=Organic Chemical; Pharmacologic Substance ;
=butenafine;
=BUTENAFINE HYDROCHLORIDE 1 % |
- 3. 1-Butanone, 1-(4-fluorophenyl)-4-[4-[(4-fluorophenyl)hydroxymethyl]-1-piperidi nyl]-
- [A butyrophenone that has been investigated for antineoplastic activity. (NCI04) ( NCI )] (UMLS (NCI) C0208317) =Organic Chemical; Pharmacologic Substance ;
| - 17. BUTORPHANOL
- [A synthetic morphinan analgesic with narcotic antagonist action. It is used in the management of severe pain. ( MSH )] (UMLS (NCI) C0006491) =Organic Chemical; Pharmacologic Substance =[CN101] OPIOID ANALGESICS;
morphinan =BUTORPHANOL TARTRATE;
|
- 4. 2-Butenoic acid, 3-bromo-4-(4-methoxyphenyl)-4-oxo-, sodium salt, (Z)- (9CI)
- (UMLS (NCI) C0893303) Acrylic acid, 3-p-anisoyl-3-bromo-, sodium salt;
Sodium Bromebrate;
Sodium cis-Beta-4-methoxybenzoyl-beta-bromacrylate =Organic Chemical; Pharmacologic Substance | - 18. butterfly
- [Slender-bodies diurnal insects having large, broad wings often strikingly colored and patterned. ( MSH )] (UMLS (CSP) C0006496) =Invertebrate ;
|
- 5. 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol
- [antihypertensive agent; nonpeptide angiotension 1 subtype; angiotension 2 receptor antagonist/inhibitor. ( CSP )] (UMLS (NCI) C0126174) =Organic Chemical; Pharmacologic Substance ;
=antihypertensive agent;
biphenyl compound;
imidazole;
Tetrazoles;
[CV805] ANGIOTENSIN II INHIBITORS;
=2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, Monopotassium Salt;
LOSARTAN 25 MG;
LOSARTAN 50 MG | - 19. Buttock
- (UMLS (HL7) C0006497) =Body Location or Region ;
=Body Part;
Body site |
- 6. 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, Monopotassium Salt
- [The potassium salt form of losartan, a non-peptide angiotensin II antagonist with antihypertensive activity. Losartan potassium selectively and competitively blocks the binding of angiotensin II to the angiotensin I (AT1) receptor. Angiotensin II, formed from angiotensin I by angiotensin-converting enzyme (ACE), stimulates the adrenal cortex to synthesize and secrete aldosterone, which decreases the excretion of sodium and increases the excretion of potassium. Angiotensin II also acts as a vasoconstrictor in vascular smooth muscle. Losartan potassium, by blocking the binding of angiotensin II to the AT 1 receptor, promotes vasodilatation and decreases the effects of aldosterone. ( NCI )] (UMLS (NCI) C0700492) =Organic Chemical; Pharmacologic Substance ;
=2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol;
=LOSARTAN POTASSIUM 25 MG;
LOSARTAN POTASSIUM 50 MG;
LOSARTAN POTASSIUM 100 MG;
| - 20. BUTTOCK CONTUSION
- [ ] (UMLS (ICD9CM) C0274220) =Injury or Poisoning
|
- 7. 5-[[2-(2-Butoxyethoxy)ethoxy]methyl]-6-propyl-1,3-benzodioxole
- [A synthetic derivative of benzodioxole and used as an insecticide synergist, Piperonyl Butoxide enhances the active properties of pyrethrin, pyrethroid, rotenone, and carbamate pesticide ingredients by inhibiting insect microsomal enzyme detoxification activity. It is toxic and suspected of causing anorexia, carcinogenesis, convulsions, and dermal irritation, as well as hepatic and renal damage. (NCI04) ( NCI )] (UMLS (NCI) C0031962) =Organic Chemical; Hazardous or Poisonous Substance =Dioxoles;
Pediculicide =PIPERONYL BUTOXIDE TECHNICAL;
PIPERONYL BUTOXIDE 3 %;
| - 21. Buttock Mass
- (UMLS (NCI) C0238869) =Finding
|
- 8. BU/TSPA
- (UMLS (NCI) C0281472) =Therapeutic or Preventive Procedure
| - 22. BUTYLSCOPOLAMINE BROMIDE
- [Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of the gastrointestinal tract. ( MSH )] (UMLS (NCI) C0006519) =Organic Chemical; Pharmacologic Substance
|
- 9. BUTABARBITAL
- (UMLS (NCI) C0006464) =Organic Chemical; Pharmacologic Substance ;
=barbiturate;
[CN301] BARBITURIC ACID DERIVATIVE, SEDATIVES/HYPNOTICS =Butabarbital Sodium;
| - 23. butyrate
- [four carbon acid, CH3CH2CH2COOH, with an unpleasant odor, that occurs in butter and animal fat as the glycerol ester; and other 4-carbon acids, salts, and derivatives. ( CSP )] (UMLS (CSP) C0006521) =Lipid ;
=Fatty Acids, Volatile;
Butyric Acid =gamma hydroxybutyrate;
phenylbutyrate;
beta hydroxybutyrate;
2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester |
- 10. Butabarbital Sodium
- (UMLS (NCI) C0304358) =Organic Chemical; Pharmacologic Substance =BUTABARBITAL;
=BUTABARBITAL NA PWDR;
BUTABARBITAL SODIUM 7.5 MG;
BUTABARBITAL SODIUM 50 MG;
BUTABARBITAL SODIUM 30 MG/5ML;
BUTABARBITAL SODIUM 15 MG;
BUTABARBITAL SODIUM 30 MG;
BUTABARBITAL SODIUM 32 MG;
BUTABARBITAL SODIUM 100 MG;
BUTABARBITAL SODIUM 15 MG/5ML | - 24. Butyrate
- (UMLS (NCI) C0220802) =Lipid
|
- 11. BUTANE
- (UMLS (NCI) C0006474) =Organic Chemical
| - 25. Butyrate Response Factor 2
- [Encoded by human oncogene ZFP36L2 Gene, 492-amino acid 50.9 kD Zinc Finger Protein 36 C3H Type-Like 2 is a putative nuclear regulatory protein containing two C3H1-type zinc fingers and involved in growth factor response. (Swiss-Prot, LocusLink, and NCI) ( NCI )] (UMLS (NCI) C0293724) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 12. Butanedioic Acid, compound with N,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine(1:1)
- [A pyridine derivate histamine H1 antagonist with pronounced sedative properties. Doxylamine succinate competitively blocks the histamine H1 receptor and limits the typical allergic and anaphylactic responses, including bronchoconstriction, vasodilation, increased capillary permeability, and spasmodic contraction of gastrointestinal smooth muscle, caused by actions of histamine on bronchial and gastrointestinal smooth muscles, and on capillaries. This drug also prevents histamine-induced pain and itching of the skin and mucous membranes. ( NCI )] (UMLS (NCI) C0058733) =Organic Chemical; Pharmacologic Substance =DOXYLAMINE;
=DOXYLAMINE SUCCINATE 25 MG;
DOXYLAMINE SUCCINATE 1.25 MG/5ML;
DOXYLAMINE SUCCINATE 6.25 MG;
DOXYLAMINE SUCCINATE 7.5 MG;
DOXYLAMINE SUCCINATE 3.75 MG;
| - 26. Butyrate sodium
- [The sodium salt of butyrate with potential antineoplastic activity. Butyrate, a short chain fatty acid, competitively binds to the zinc sites of class I and II histone deacetylases (HDACs), leading to hyperacetylation of histones and resulting in a modified DNA conformation, which subsequently leads to the uncoiling or relaxing of chromatin; enhanced accessibility of chromatin to transcription-regulatory complexes leads to increased transcriptional activation of various epigenetically suppressed genes. Butyrate, a HDAC inhibitor, induces cell cycle arrest in G1 or G2/M and also increases the expression of other genes and proteins involved in cellular differentiation and apoptotic signaling ( NCI )] (UMLS (NCI) C0142812) =Lipid; Pharmacologic Substance ;
|
- 13. Butanedioic Acid,((dimethoxyphosphinothioyl)thio)-, Diethyl Ester
- [A synthetic phosphorous compound and cholinesterase inhibitor that is strictly used as a topical pediculicide. Malathion exerts its action on the nervous system of the lice by irreversibly inhibiting the activity of cholinesterase, thereby allowing acetylcholine to accumulate at cholinergic synapses and enhancing cholinergic receptor stimulation. This eventually leads to the head lice's death. ( NCI )] (UMLS (NCI) C0024547) =Organophosphorus Compound; Pharmacologic Substance; Hazardous or Poisonous Substance =Organothiophosphorus Compounds;
Pediculicide =MALATHION 0.5 % | - 27. butyrolactone
- [ ] (UMLS (CSP) C0178525) =Organic Chemical; Pharmacologic Substance =LACTONE;
Unclassified Ingredients;
Inactive Ingredient Preparations;
=UREA 25% LOTION;
|
- 14. Butanoic acid, 2-amino-4-(methylseleno)-
- [methionine in which selenium replaces the sulfur atom; the radioactive form is used in tests of tissue uptake of methionine. ( CSP )] (UMLS (NCI) C0036584) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =L-Methionine;
Organoselenium Compound;
selenated sulfur aminoacid;
=SELENOMETHIONINE SE 75;
| - 28. butyrophenone
- [Synthetic agents containing the phenyl-1-butanone group, most Butyrophenones are neuroleptic (antipsychotic) drugs, such as haloperidol, droperidol, or azaperone, that control schizophrenic symptoms (hallucinations, delusions, dementia). Most antipsychotic agents interfere with neurotransmitter functions, usually blocking dopamine receptors, and induce behavioral, endocrine, motor-kinetic effects. (NCI04) ( NCI )] (UMLS (CSP) C0006525) =Organic Chemical; Pharmacologic Substance =KETONE;
=droperidol;
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone |
home
